Innovent Biologics' newly launched weight-loss drug is making inroads in its home market of China, ramping up competition ...

Swiss drugmaker Roche signalled its ambition to join Eli Lilly and Novo Nordisk at the top of the booming weight-loss market ...

Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up to $7.3 billion, including future ...

Pfizer said on Monday it would acquire weight-loss drug developer Metsera in a deal valued up to $7.3 billion, which includes ...

Novo Nordisk said participants who took the once-daily pill in a clinical trial lost an average 16% of their body weight.

When someone gains weight, their skin adapts and stretches, but when they lose weight their skin can remain stretched, ...

An experimental GLP-1 pill called orforglipron promoted substantial weight loss without the need for weekly injections, ...

As the new Chief Wellness Amassador at Noom, a weight loss platform, Rebel Wilson is endorsing their GLP-1 'microdosing' ...

New research reveals that GLP-1 drugs may significantly lower mortality rates in Americans by 2045, as obesity contributes to ...

Makers of GLP-1 drugs, including Novo Nordisk, Eli Lilly and others, are close to releasing daily pills to help shed pounds ...

The drug. orforglipron, works on the same receptor as semaglutide (Ozempic/Wegovy), but can be taken without restrictions on ...

The research, published in the journal Diabetes, Obesity and Metabolism, suggests that the injectable GLP-1 drugs may make ...